These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17381177)

  • 41. Quantitative structure-activity relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation.
    Basak SC; Mills D; Hawkins DM; Kraker JJ
    Chem Biodivers; 2009 Apr; 6(4):487-502. PubMed ID: 19353545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimized block-wise variable combination by particle swarm optimization for partial least squares modeling in quantitative structure-activity relationship studies.
    Lin WQ; Jiang JH; Shen Q; Shen GL; Yu RQ
    J Chem Inf Model; 2005; 45(2):486-93. PubMed ID: 15807514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques.
    Garg D; Gandhi T; Gopi Mohan C
    J Mol Graph Model; 2008 Feb; 26(6):966-76. PubMed ID: 17928249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel descriptor of amino acids and its application in peptide QSAR.
    Tong J; Liu S; Zhou P; Wu B; Li Z
    J Theor Biol; 2008 Jul; 253(1):90-7. PubMed ID: 18397794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. QSAR modeling of the interaction of flavonoids with GABA(A) receptor.
    Duchowicz PR; Vitale MG; Castro EA; Autino JC; Romanelli GP; Bennardi DO
    Eur J Med Chem; 2008 Aug; 43(8):1593-602. PubMed ID: 18158201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR methodology.
    Ijjaali I; Petitet F; Dubus E; Barberan O; Michel A
    Bioorg Med Chem; 2007 Jun; 15(12):4256-64. PubMed ID: 17451961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of MLR, PLS and GA-MLR in QSAR analysis.
    Saxena AK; Prathipati P
    SAR QSAR Environ Res; 2003; 14(5-6):433-45. PubMed ID: 14758986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimalarial activity: a QSAR modeling using CODESSA PRO software.
    Katritzky AR; Kulshyn OV; Stoyanova-Slavova I; Dobchev DA; Kuanar M; Fara DC; Karelson M
    Bioorg Med Chem; 2006 Apr; 14(7):2333-57. PubMed ID: 16426851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QSAR analysis of phenolic antioxidants using MOLMAP descriptors of local properties.
    Gupta S; Matthew S; Abreu PM; Aires-de-Sousa J
    Bioorg Med Chem; 2006 Feb; 14(4):1199-206. PubMed ID: 16230016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QSTR with extended topochemical atom (ETA) indices. 12. QSAR for the toxicity of diverse aromatic compounds to Tetrahymena pyriformis using chemometric tools.
    Roy K; Ghosh G
    Chemosphere; 2009 Nov; 77(7):999-1009. PubMed ID: 19709717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM; Taha MO
    J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity.
    Prabhakar YS; Gupta MK; Roy N; Venkateswarlu Y
    J Chem Inf Model; 2006; 46(1):86-92. PubMed ID: 16426043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LQTA-QSAR: a new 4D-QSAR methodology.
    Martins JP; Barbosa EG; Pasqualoto KF; Ferreira MM
    J Chem Inf Model; 2009 Jun; 49(6):1428-36. PubMed ID: 19422246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
    Santos-Filho OA; Cherkasov A
    J Chem Inf Model; 2008 Oct; 48(10):2054-65. PubMed ID: 18816024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. QSAR study of 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide as PARP inhibitors for treatment of cancer.
    Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
    Chem Biol Drug Des; 2008 Dec; 72(6):575-84. PubMed ID: 19090924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative structure-activity relationship modeling of the toxicity of organothiophosphate pesticides to Daphnia magna and Cyprinus carpio.
    Zvinavashe E; Du T; Griff T; van den Berg HH; Soffers AE; Vervoort J; Murk AJ; Rietjens IM
    Chemosphere; 2009 Jun; 75(11):1531-8. PubMed ID: 19376559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key study.
    Bacilieri M; Varano F; Deflorian F; Marini M; Catarzi D; Colotta V; Filacchioni G; Galli A; Costagli C; Kaseda C; Moro S
    J Chem Inf Model; 2007; 47(5):1913-22. PubMed ID: 17722877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.